Zink Gregory L

Director Zink Gregory L purchases 1,000 shares of NEWT in open-market buy, 16th open-market purchase in 36 months with mixed prior timing outcomes.

Director Zink Gregory L added to his stake with an open-market purchase of 1,000 shares, continuing a consistent pattern of accumulation—this is his 16th open-market purchase over the past three years with no open-market sales. The stock is trading modestly below its 52-week high, having climbed sharply over the prior month from depressed levels. His prior five trades at NEWT show mixed timing results: four of five purchases saw the stock rise in the subsequent month, though the 90-day picture was more split, with three trades followed by gains and two followed by declines. NewtekOne remains a profitable company with a low valuation multiple relative to earnings and solid recent quarterly results, providing a financial backdrop to the accumulation. The persistence of open-market buying—especially given the mixed but not poor near-term track record—underscores steady conviction in the business at current levels.

Director Zink Gregory L buys 500 NEWT shares at $12.06; cluster pattern with 2 other insiders buying within 14 days.

Director Zink Gregory L purchased 500 shares at $12.06 on 2025-12-15, increasing holdings by 1.3% to 37,707 shares. The purchase occurs as part of a cluster pattern, with 2 other insiders also buying within the past 14 days, suggesting coordinated interest in the stock at current levels. At the time of this purchase, the stock was trading -17.0% from its 52-week high and had appreciated +17.6% over the preceding 30 days, placing the transaction near a relative peak within recent momentum cycles. Examining the director's prior 5 trades at NEWT shows mixed timing outcomes: 2 of 4 completed trades (50%) delivered positive 90-day returns, while 2 experienced declines, indicating modest predictive value in his ticker-specific activity; his cross-ticker track record shows a 38.46% win rate over 90 days, further suggesting limited historical success at identifying optimal entry points.

Director Zink Gregory L bought 1,000 shares of NEWT at $10.43; stock down 32.2% from 52-week high of $15.46.

Director Zink Gregory L purchased 1,000 shares at $10.43, increasing holdings from 36,207 to 37,207 shares. The stock has declined 7.6% over 30 days and 6.4% over 90 days, currently trading at $10.49—down 32.2% from the 52-week high of $15.46. At this ticker, his prior 5 trades show mixed timing: 2 of 5 achieved positive 90-day returns (well-timed buys), while 2 of 5 suffered declines. His cross-ticker track record across 13 prior buys averaged +1.8% over 30 days and +0.5% over 90 days, with a 38.46% win rate. The company reports strong fundamentals—$38,166,000.00 quarterly revenue, $13,703,000.00 net income, and a P/E of 5.17—suggesting valuation may be depressed relative to earnings. The purchase occurs in a period of stock weakness, but without scheduled trade plan disclosure, the motivation for this timing remains unclear from filing data alone.

Director Zink Gregory L bought 2,000 shares at blended $10.39 on 2025-05-09 (part of 3-insider cluster buy pattern).

Zink Gregory L, a NewtekOne director, executed 2 separate purchases totaling 2,000 shares for $20,780.00 on 2025-05-09, raising his holdings from 31,924 to 33,924 shares. The filing is part of a documented cluster pattern where 2 other insiders also bought within the past 14 days, suggesting coordinated confidence at current valuation levels. His same-ticker buy history at NEWT shows mixed timing outcomes: only 1 of 4 measurable prior buys achieved positive 90-day returns, with the most recent buy on 2025-03-21 declining -17.1% within 30 days. The current stock price of $11.14 is -27.9% from its 52-week high of $15.46, and the company trades at a P/E of 5.80 on quarterly revenue of $38,166,000.00 and net income of $9,367,000.00, providing a quantifiable valuation context for the purchase. This buy reflects director-level accumulation during a period of broader insider activity, though his prior execution at this ticker has not demonstrated consistent forward-looking accuracy.

Director Zink Gregory L buys 500 shares of NEWT at $12.34; post-transaction holdings 31,924 shares, up 1.6%.

Director Zink Gregory L purchased 500 shares at $12.34 on March 21, 2025, bringing his holdings to 31,924 shares. The stock currently trades at $12.52, within its 52-week range of $10.19–$15.46 and 19.0% below the 52-week high. Examining his prior trade history at NEWT specifically: of 5 prior buys at this ticker, only 1 achieved a positive 90-day return (the September 18, 2024 buy, which returned +15.9% over 90 days), while the others showed negative outcomes ranging from -3.2% to -14.6%. His cross-ticker track record shows 10 prior open-market buys with an average 90-day return of +0.3% and a 30.00% 90-day win rate. The fundamental backdrop includes a quarterly net income of $11,934,000.00 and a P/E of 5.99, suggesting valuation support, but the insider's recent purchase history at NEWT does not demonstrate consistent timing acuity at this ticker.

Director Zink Gregory L purchases 500 NEWT shares at $12.75; stock -10.6% in 30 days; cluster of 4 other insider buys in 14 days.

Director Zink Gregory L acquired 500 shares of NewtekOne at $12.75 on 2024-12-23, expanding holdings by 1.5% to 33,517 shares. The purchase occurs against mixed recent price action: NEWT is down 10.6% over 30 days and 16.0% from its 52-week high of $15.46, though up 7.3% over 90 days. At the NEWT-specific level, his prior 5 trades show uneven timing—only 1 of 4 measurable 90-day outcomes was well-timed, and two consecutive May buys each fell 11–14% within 30 days. This current buy coincides with a 4-insider cluster pattern within the past 14 days. The company shows solid fundamentals: P/E of 6.66, net income of $11,934,000.00, and market cap of $341,702,677.44. The convergence of multiple insider acquisitions during a period of near-term price weakness warrants attention to whether the cluster represents genuine confidence or merely coincidental timing.

Director Zink Gregory L buys 1,000 NEWT shares at $13.95; holds 33,017 shares post-transaction

Zink Gregory L, a director, purchased 1,000 shares of NewtekOne (NEWT) at $13.95, increasing his holdings from 32,017 to 33,017 shares. This represents a modest 3.1% addition to his existing position. The purchase occurs in a stock trading at $13.80, some 10.7% below its 52-week high of $15.46, and his prior trades at NEWT show a poor pattern: 0 of 4 measurable prior buys were well-timed at the 90-day mark, with three producing negative 90d returns (-13.0%, -14.2%, -14.6%, and -11.0%). While the company shows solid fundamentals with a P/E of 7.08 and recent net income of $11,934,000.00, the director's historical timing at this ticker offers no clear validation that this purchase represents a forward-looking inflection point.

Director Gregory L Zink bought 1,000 shares of NEWT at $11.38 on 2024-09-18; stock down 30.6% from 52-week high.

Zink purchased 1,000 shares at $11.38, increasing his holdings by 3.2% to 32,017 shares. NEWT trades at $11.61, down 30.6% from its 52-week high of $16.72, placing the stock near the lower end of its annual range. The company reports a P/E of 6.11 with net income of $10,945,000.00 on revenue of $38,166,000.00, suggesting financial stability. However, Zink's prior trading record at this ticker reveals a consistent pattern of poor timing: across 5 prior purchases at NEWT, 0 of the 5 trades were well-timed at the 90-day mark, with the most recent buy on 2024-06-17 showing a 90d return of -13.0% and earlier buys returning -14.2%, -14.6%, -11.0%, and -19.0% over 90 days. This accumulation occurs within a context of ongoing price weakness and a track record of uninformed entry points at this specific ticker.

Director Zink Gregory L bought 1,000 shares of NEWT at $12.92 on 2024-06-17; 2 other insiders also bought within 14 days.

Zink Gregory L (Director) purchased 1,000 shares at $12.92 on 2024-06-17, expanding his position to 29,085 shares. The stock is currently trading at $12.90, down 33.0% from its 52-week high of $19.24, and Zink's prior trades at NEWT show a mixed track record: of 5 prior same-ticker trades, only 1 of 3 buys was well-timed at the 90-day mark, with measurable outcomes ranging from -19.3% to +10.3% over 30 days and -19.0% to +16.3% over 90 days. A cluster buy pattern is present—2 other insiders also acquired shares within the past 14 days. Fundamentals remain intact with revenue of $38,166,000.00 and net income of $9,650,000.00, yielding a low P/E of 7.05, but the director's historical execution at this ticker does not demonstrate a consistent ability to identify entry points before subsequent appreciation.